Next-day assessment of hereditary cancer risk using a targeted NGS panel
Please log in for more information
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Paragon Genomics specializes in library preparation for targeted next-generation sequencing (NGS). Paragon develops and commercializes best-in-class amplicon-based target enrichment solutions for genomics analysis of clinically-relevant samples.